Common Stock, Shares, Outstanding of Ensysce Biosciences, Inc. from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Ensysce Biosciences, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • Ensysce Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 3,181,074, a 77% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Ensysce Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 3,181,074 -10,689,436 -77% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 2,393,256 -5,757,916 -71% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 1,644,728 -5,684,444 -78% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 1,355,773 +1,146,034 +546% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 13,870,510 +11,006,506 +384% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 8,151,172 +5,481,380 +205% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 7,329,172 +6,044,589 +471% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 209,739 -324,751 -61% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 2,864,004 +656,546 +30% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 2,669,792 -32,860,487 -92% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 1,284,583 -28,664,449 -96% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 534,490 -697,670 -57% 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q3 2022 2,207,458 -22,048,328 -91% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 35,530,279 +35,219,316 +11326% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 29,949,032 +23,724,764 +381% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 1,232,160 -14,536,565 -92% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 24,255,786 +17,998,659 +288% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 310,963 -5,946,164 -95% 30 Jun 2021 10-K 30 Mar 2023 2022 FY
Q1 2021 6,224,268 -380,517 -5.8% 31 Mar 2021 10-Q 08 Jun 2021 2021 Q1
Q4 2020 15,768,725 +8,701,303 +123% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 6,257,127 +117,603 +1.9% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 6,257,127 +156,909 +2.6% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 6,604,785 +556,921 +9.2% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 7,067,422 +1,028,350 +17% 31 Dec 2019 10-K/A 08 Jun 2021 2020 FY
Q3 2019 6,139,524 +113,682 +1.9% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 6,100,218 +90,069 +1.5% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 6,047,864 0 0% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 6,039,072 -695,248 -10% 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q3 2018 6,025,842 -1,161,658 -16% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 6,010,149 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 6,047,864 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q4 2017 6,734,320 31 Dec 2017 10-K/A 12 Mar 2019 2018 FY
Q3 2017 7,187,500 30 Sep 2017 10-Q 09 Jan 2018 2017 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.